Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1544-1550
Published online before print March 12, 2007, doi: 10.1161/CIRCULATIONAHA.106.658948
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: March 27, 2007, Volume 115, Number 12
Right arrow All Versions of this Article:
115/12/1544    most recent
CIRCULATIONAHA.106.658948v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow patientINFORMation
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fox, C. S.
Right arrow Articles by Savage, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, C. S.
Right arrow Articles by Savage, P. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Diabetes Complications
Related Collections
Right arrow Epidemiology
Right arrow Type 2 diabetes
Right arrow Risk Factors

(Circulation. 2007;115:1544-1550.)
© 2007 American Heart Association, Inc.


Epidemiology

Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus

The Framingham Heart Study

Caroline S. Fox, MD, MPH; Sean Coady, MA; Paul D. Sorlie, PhD; Ralph B. D’Agostino, Sr, PhD; Michael J. Pencina, PhD; Ramachandran S. Vasan, MD; James B. Meigs, MD, MPH; Daniel Levy, MD; Peter J. Savage, MD

From the National Heart, Lung, and Blood Institute’s Framingham Heart Study (C.S.F., D.L.), Framingham, Mass; Brigham and Women’s Hospital, Department of Endocrinology, Diabetes, and Hypertension, Harvard Medical School, Boston, Mass (C.S.F.); General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (J.B.M.); Department of Mathematics, Boston University, Boston, Mass (R.B.D., M.J.P.); Boston University School of Medicine (R.S.V.), Boston, Mass; and the National Heart, Lung, and Blood Institute, National Institutes of Health (C.S.F., S.C., P.D.S., D.L., P.J.S.), Bethesda, Md.

Correspondence to Caroline S. Fox, MD, MPH, Framingham Heart Study, 73 Mt Wayte Ave, Suite 2, Framingham, MA 01702-5827. E-mail foxca{at}nhlbi.nih.gov

Received August 16, 2006; accepted December 19, 2006.

Background— Marked reductions in cardiovascular disease (CVD) morbidity and mortality have occurred in the United States over the last 50 years. We tested the hypothesis that the relative burden of CVD attributable to diabetes mellitus (DM) has increased over the past 5 decades.

Methods and Results— Participants aged 45 to 64 years from the Framingham Heart Study, who attended examinations in an "early" time period (1952 to 1974), were compared with those who attended examinations in a later time period (1975 to 1998). The risk of CVD events (n=133 among those with and 1093 among those without DM) attributable to DM in the 2 time periods was assessed with Cox proportional hazards models; population attributable risk of DM as a CVD risk factor was calculated for each time period. The age- and sex-adjusted hazard ratio for DM as a CVD risk factor was 3.0 (95% CI, 2.3 to 3.9) in the earlier time period and 2.5 (95% CI, 1.9 to 3.2) in the later time period. The population attributable risk for DM as a CVD risk factor increased from 5.4% (95% CI, 3.8% to 6.9%) in the earlier time period to 8.7% (95% CI, 5.9% to 11.4%) in the later time period (P for attributable risk ratio=0.04), although multivariable adjustment resulted in attenuation of these findings (P=0.12); most of these observations were found among men.

Conclusions— The proportion of CVD attributable to DM has increased over the past 50 years in Framingham. These findings emphasize the need for increased efforts to prevent DM and to aggressively treat and control CVD risk factors among those with DM.


 

CLINICAL PERSPECTIVE


Find additional patient-related information at:

Diabetes Increasingly Linked to Cardiovascular Disease


This article has been cited by other articles:


Home page
Diabetes CareHome page
C. S. Fox and P. Muntner
Trends in Diabetes, High Cholesterol, and Hypertension in Chronic Kidney Disease Among U.S. Adults: 1988-1994 to 1999-2004
Diabetes Care, July 1, 2008; 31(7): 1337 - 1342.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
The ADVANCE Collaborative Group
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
N. Engl. J. Med., June 12, 2008; 358(24): 2560 - 2572.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Rewers
Why Do People With Diabetes Die Too Soon?: More questions than answers
Diabetes Care, April 1, 2008; 31(4): 830 - 832.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sanz, P. R. Moreno, and V. Fuster
The year in atherothrombosis.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 944 - 955.
[Full Text] [PDF]


Home page
Diabetes CareHome page
J. Fradkin and G. P. Rodgers
The Economic Imperative to Conquer Diabetes
Diabetes Care, March 1, 2008; 31(3): 624 - 625.
[Full Text] [PDF]


Home page
CirculationHome page
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation, January 29, 2008; 117(4): e25 - e146.
[Full Text] [PDF]